Below are transcripts (PDF) for all of the speakers at the CMS patient-focused listening sessions. Where possible, we’ve provided affiliations. CMS refers to speakers only with their first name, so — unless speakers more fully identify themselves — we’ve used only their first names here as well.
The Eliquis sessions are not complete. I’d initially expected that replays would be available for the sessions. The lack of any recording meant that all speakers could not be captured. We prepared accordingly for the remaining sessions, so — with the exception of Eliquis — this should be a full accounting of all ten sessions.
Without the benefit of replay, there may be inadvertent errors introduced. If you see something that requires correction, please let me know.
This is a service of Cost Curve, a daily newsletter on all things drug pricing and policy. To subscribe, click here.